The Latest in CLL

EHA: Venetoclax-rituxumab combo highly active in relapsed/refractory CLL

June 12, 2015

CLL

Chronic lymphocytic leukemia prognosis relatively good after transplantation failure

April 6, 2015

Ofatumumab maintenance halves risk of progression in relapsed CLL

December 7, 2014

VIDEO: Are chemo-free regimens possible for CLL?

September 26, 2014

CLL

VIDEO: ABT-199 alone and in combination shows promise against advanced CLL

August 5, 2014

CLL

FDA gives full approval to ibrutinib for CLL

July 28, 2014

CLL

ABT-199 rebounds in advanced CLL after tackling tumor lysis syndrome

July 21, 2014

ONO-4059 delivered hit to relapsed/refractory CLL

July 14, 2014

CLL

Idelalisib efficacy remains rock steady in relapsed CLL

June 23, 2014

CLL

Ibrutinib holds CLL at bay in majority of patients at 30 months

June 17, 2014

CLL

VIDEO: Ibrutinib boosts survival of relapsed/refractory CLL

June 2, 2014

CLL

Drugs approved in 2013

May 21, 2014

FDA approves ofatumumab for chronic lymphocytic leukemia

April 17, 2014

CLL

Persistent lymphocytosis with ibrutinib does not indicate early relapse

March 28, 2014

CLL

Idelalisib and rituximab extends survival in CLL patients

January 22, 2014

CLL